Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea · Delayed Price · Currency is KRW

41,150

-1,300 (-3.06%)

At close: Jul 16, 2026

5.11% (1Y)

Market Cap	707.91B +11.9%
Revenue (ttm)	5.55B +41.6%
Net Income	-26.20B
EPS	-1,563.11
Shares Out	17.20M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	98,181
Open	42,400
Previous Close	42,450
Day's Range	40,450 - 43,300
52-Week Range	35,350 - 149,200
Beta	1.95
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 14, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus

Founded 2018

Country South Korea

Stock Exchange KOSDAQ

Ticker Symbol 445680

Full Company Profile

Financial Performance

In 2025, Curiox Biosystems's revenue was 5.15 billion, an increase of 12.29% compared to the previous year's 4.59 billion. Losses were -27.18 billion, 236.0% more than in 2024.

Financial Statements